Xiao He

1.1k total citations
44 papers, 818 citations indexed

About

Xiao He is a scholar working on Molecular Biology, Genetics and Cancer Research. According to data from OpenAlex, Xiao He has authored 44 papers receiving a total of 818 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 10 papers in Genetics and 10 papers in Cancer Research. Recurrent topics in Xiao He's work include Mesenchymal stem cell research (8 papers), Cancer-related molecular mechanisms research (7 papers) and MicroRNA in disease regulation (4 papers). Xiao He is often cited by papers focused on Mesenchymal stem cell research (8 papers), Cancer-related molecular mechanisms research (7 papers) and MicroRNA in disease regulation (4 papers). Xiao He collaborates with scholars based in China, United States and Hong Kong. Xiao He's co-authors include Xiang Xu, Yi Yang, Wei Guo, Wei Xing, Dongpo Jiang, Luoquan Ao, Ming Zhu, Wei Guo, Xiaofeng Wu and Yiping Wu and has published in prestigious journals such as Scientific Reports, Diabetologia and British Journal of Pharmacology.

In The Last Decade

Xiao He

44 papers receiving 797 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiao He China 18 404 236 192 148 134 44 818
Haifeng Zhao China 19 358 0.9× 253 1.1× 85 0.4× 156 1.1× 172 1.3× 83 1.0k
Vitale Miceli Italy 18 361 0.9× 225 1.0× 331 1.7× 84 0.6× 107 0.8× 57 924
Saeid Shahrabi Iran 17 323 0.8× 155 0.7× 212 1.1× 152 1.0× 156 1.2× 49 872
Jun Shi China 21 582 1.4× 196 0.8× 310 1.6× 302 2.0× 150 1.1× 111 1.4k
Joon Ho Lee South Korea 19 371 0.9× 149 0.6× 78 0.4× 173 1.2× 161 1.2× 45 999
Melvin M. Denis United States 8 511 1.3× 178 0.8× 70 0.4× 231 1.6× 149 1.1× 9 1.2k
Craig E. Higgins United States 19 522 1.3× 313 1.3× 62 0.3× 104 0.7× 177 1.3× 26 1.1k
Minglin Ou China 17 467 1.2× 248 1.1× 50 0.3× 150 1.0× 146 1.1× 82 900
Ying Xie China 16 492 1.2× 157 0.7× 104 0.5× 83 0.6× 129 1.0× 50 805
Chuanyu Wei China 20 506 1.3× 287 1.2× 81 0.4× 158 1.1× 86 0.6× 38 1.1k

Countries citing papers authored by Xiao He

Since Specialization
Citations

This map shows the geographic impact of Xiao He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiao He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiao He more than expected).

Fields of papers citing papers by Xiao He

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiao He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiao He. The network helps show where Xiao He may publish in the future.

Co-authorship network of co-authors of Xiao He

This figure shows the co-authorship network connecting the top 25 collaborators of Xiao He. A scholar is included among the top collaborators of Xiao He based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiao He. Xiao He is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Hong, Peng Zhang, Minghui Lin, et al.. (2025). Pyroptosis: candidate key targets for mesenchymal stem cell-derived exosomes for the treatment of bone-related diseases. Stem Cell Research & Therapy. 16(1). 68–68. 5 indexed citations
2.
Li, Li, et al.. (2023). A global bibliometric and visualized analysis of the status and trends of bone metastasis in breast cancer research from 2002 to 2021. Journal of bone oncology. 42. 100500–100500. 2 indexed citations
3.
Chen, Yong, Hong Ye, Baoqiang Wang, et al.. (2022). Circ-LARP1B knockdown restrains the tumorigenicity and enhances radiosensitivity by regulating miR-578/IGF1R axis in hepatocellular carcinoma. Annals of Hepatology. 27(2). 100678–100678. 13 indexed citations
4.
Yu, Honghao, Wenchang Lv, Yufang Tan, et al.. (2022). Immunotherapy landscape analyses of necroptosis characteristics for breast cancer patients. Journal of Translational Medicine. 20(1). 328–328. 11 indexed citations
5.
He, Xiao, Yiwei Qi, Xian Zhang, et al.. (2021). Current landscape of tumor-derived exosomal ncRNAs in glioma progression, detection, and drug resistance. Cell Death and Disease. 12(12). 1145–1145. 35 indexed citations
6.
Liu, Xingli, et al.. (2021). Downregulating LncRNA XIST attenuated contrast-induced nephropathy injury via regulating miR-133a-3p/NLRP3 axis. Journal of Thrombosis and Thrombolysis. 52(2). 440–453. 9 indexed citations
7.
Yang, Yi, Xiao He, Wei Guo, et al.. (2021). Correction to: Serum IFN-γ levels predict the therapeutic effect of mesenchymal stem cell transplantation in active rheumatoid arthritis. Journal of Translational Medicine. 19(1). 2 indexed citations
8.
Wang, Dan, Jingyi Cheng, Jia Zhang, et al.. (2021). The Role of Respiratory Microbiota in Lung Cancer. International Journal of Biological Sciences. 17(13). 3646–3658. 31 indexed citations
9.
Guo, Wei, Wei Qiu, Xiang Ao, et al.. (2020). Low‐concentration DMSO accelerates skin wound healing by Akt/mTOR‐mediated cell proliferation and migration in diabetic mice. British Journal of Pharmacology. 177(14). 3327–3341. 28 indexed citations
10.
He, Xiao, Wei Guo, Yi Yang, et al.. (2018). Umbilical cord-derived mesenchymal stem (stromal) cells for treatment of severe sepsis: aphase 1 clinical trial. Translational research. 199. 52–61. 54 indexed citations
11.
Yang, Yi, Xiao He, Wei Guo, et al.. (2018). Serum IFN-γ levels predict the therapeutic effect of mesenchymal stem cell transplantation in active rheumatoid arthritis. Journal of Translational Medicine. 16(1). 165–165. 60 indexed citations
12.
Yuan, Xiaopeng, et al.. (2016). Organ Donation and Transplantation From Donors With Systemic Infection: A Single-Center Experience. Transplantation Proceedings. 48(7). 2454–2457. 11 indexed citations
13.
He, Xiao, Guixing Xu, Wenhua Liang, et al.. (2015). Nomogram for Predicting Time to Death After Withdrawal of Life-Sustaining Treatment in Patients With Devastating Neurological Injury. American Journal of Transplantation. 15(8). 2136–2142. 16 indexed citations
14.
Li, Xiangyun, Ming Zhu, Wei Guo, et al.. (2015). Ligustrazine Suppresses the Growth of HRPC Cells through the Inhibition of Cap- Dependent Translation Via Both the mTOR and the MEK/ERK Pathways. Anti-Cancer Agents in Medicinal Chemistry. 15(6). 764–772. 18 indexed citations
15.
Zhang, Kun, et al.. (2014). Decreased P‐glycoprotein is associated with the inhibitory effects of static magnetic fields and cisplatin on K562 cells. Bioelectromagnetics. 35(6). 437–443. 8 indexed citations
16.
He, Xiao, et al.. (2014). MiR-218 regulates cisplatin chemosensitivity in breast cancer by targeting BRCA1. Tumor Biology. 36(3). 2065–2075. 50 indexed citations
17.
Ying, Yong, et al.. (2013). Effects of vasopressin infusion aided prophylactic gastroduodenal artery embolization in DSA-negative gastrointestinal bleeding patients. World Chinese Journal of Digestology. 21(36). 4180–4180. 3 indexed citations
18.
He, Xiao, Lan Xiao, Juan Han, et al.. (2012). Late Embryonic and Postnatal Development of Interstitial Cells of Cajal in Mouse Esophagus: Distribution, Proliferation and Kit Dependence. Cells Tissues Organs. 196(2). 175–188. 6 indexed citations
19.
Li, Xiuyang, Hao Li, Xin Du, et al.. (2008). Early initiation of tacrolimus or cyclophosphamide therapy for idiopathic membranous nephropathy with severe proteinuria. Journal of Nephrology. 21(4). 584–591. 27 indexed citations
20.
He, Xiao. (2003). The efficacy and safety of Prostant ~(TM) in the treatment of chronic prostatitis: a multi-center,randomized,double-blind,placebo-controlled clinical trial. Zhonghua miniao waike zazhi. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Haifeng Zhao Breakdown of academic impact, for papers by Vitale Miceli Breakdown of academic impact, for papers by Saeid Shahrabi Breakdown of academic impact, for papers by Jun Shi Breakdown of academic impact, for papers by Joon Ho Lee Breakdown of academic impact, for papers by Melvin M. Denis Breakdown of academic impact, for papers by Craig E. Higgins Breakdown of academic impact, for papers by Minglin Ou Breakdown of academic impact, for papers by Ying Xie Breakdown of academic impact, for papers by Chuanyu Wei
Rankless by CCL
2026